{"id":"https://openalex.org/W7236644875","doi":"https://doi.org/10.20944/preprints202611.1928.v1","title":"The Probe-lem Solved? The Road Toward an In Vivo, ATP-competitive CK2 Chemical Probe","display_name":"The Probe-lem Solved? The Road Toward an In Vivo, ATP-competitive CK2 Chemical Probe","alternate_titles":[],"publication_year":2026,"publication_date":"2026-11-18","ids":{"openalex":"https://openalex.org/W7236644875","doi":"https://doi.org/10.20944/preprints202611.1928.v1"},"language":"en","primary_location":{"id":"doi:10.20944/preprints202611.1928.v1","doi":"https://doi.org/10.20944/preprints202611.1928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.1928.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W7236644875"],"child_works_count":0,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.20944/preprints202611.1928.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5162829666","display_name":"Ross H. Sibley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ross H. Sibley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5122969520","display_name":"Alison Axtman","orcid":"https://orcid.org/0000-0003-4779-9932","observed_orcids":["https://orcid.org/0000-0003-4779-9932"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alison D. Axtman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5122969520"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.09799999743700027,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.08410000056028366,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/casein-kinase-2","display_name":"casein kinase 2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ck2-inhibitors","display_name":"CK2 inhibitors","score":0.8429999947547913},{"id":"https://openalex.org/keywords/chemical-probes","display_name":"chemical probes","score":0.7940000295639038},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/pyrazolo-1-5-a-pyrimidines","display_name":"pyrazolo[1,5-a]pyrimidines","score":0.9539999961853027},{"id":"https://openalex.org/keywords/bivalent-inhibitors","display_name":"bivalent inhibitors","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9520000219345093},{"id":"https://openalex.org/keywords/in-vivo-activity","display_name":"in vivo activity","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6151999831199646},{"id":"https://openalex.org/C143910341","wikidata":"https://www.wikidata.org/wiki/Q21102140","display_name":"Casein kinase 2","level":5,"score":0.4984999895095825},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.45969998836517334},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4537000060081482},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.45080000162124634},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.435699999332428},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3434000015258789},{"id":"https://openalex.org/C2984430287","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutical technology","level":2,"score":0.34040001034736633},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2906000018119812},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.28060001134872437},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28029999136924744},{"id":"https://openalex.org/C2986762682","wikidata":"https://www.wikidata.org/wiki/Q964754","display_name":"Basic research","level":2,"score":0.27079999446868896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2639999985694885},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C171852809","wikidata":"https://www.wikidata.org/wiki/Q731154","display_name":"Chemical biology","level":2,"score":0.25519999861717224},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.20944/preprints202611.1928.v1","doi":"https://doi.org/10.20944/preprints202611.1928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.1928.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.20944/preprints202611.1928.v1","doi":"https://doi.org/10.20944/preprints202611.1928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.1928.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8335999846458435,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388140204","https://openalex.org/W3125457212","https://openalex.org/W3147640036","https://openalex.org/W3141905478","https://openalex.org/W4393187008","https://openalex.org/W4239761756","https://openalex.org/W2015551314","https://openalex.org/W2092771170","https://openalex.org/W4324132784","https://openalex.org/W4396601705"],"abstract_inverted_index":{"The":[0],"complexity":[1],"of":[2,45,101,168],"casein":[3],"kinase":[4],"2":[5],"(CK2/CSNK2;":[6],"encoded":[7],"by":[8,110,161],"CSNK2A1,":[9],"CSNK2A2,":[10],"and":[11,13,27,66,91,117,144],"CSNK2B)":[12],"its":[14,23,137,152],"regulatory":[15],"roles":[16],"across":[17],"numerous":[18],"cellular":[19,85],"pathways":[20],"both":[21],"underscores":[22],"broad":[24],"therapeutic":[25],"potential":[26],"complicates":[28],"efforts":[29],"to":[30],"define":[31],"the":[32,43,99,106,122],"contexts":[33],"in":[34,76,94,131,146],"which":[35],"CK2":[36,53,69,78,133,169],"inhibition":[37],"may":[38],"be":[39],"clinically":[40],"beneficial.":[41],"Accordingly,":[42],"development":[44],"high-quality":[46],"chemical":[47],"probes":[48],"remains":[49],"essential":[50],"for":[51,93,165],"elucidating":[52],"biology.":[54,170],"Since":[55],"2023,":[56],"substantial":[57],"progress":[58],"has":[59,126],"been":[60],"made":[61],"toward":[62,129],"identifying":[63],"potent,":[64],"selective,":[65],"pharmacologically":[67],"relevant":[68],"inhibitors.":[70],"Here,":[71],"we":[72],"summarize":[73],"recent":[74],"advances":[75],"ATP-competitive":[77],"inhibitor":[79,119],"development,":[80],"with":[81],"particular":[82],"emphasis":[83],"on":[84,136],"activity,":[86],"kinome-wide":[87,142],"selectivity,":[88,143],"pharmacokinetic":[89],"properties,":[90],"suitability":[92],"vivo":[95,132,147],"studies.":[96],"We":[97,159],"discuss":[98],"optimization":[100],"established":[102],"monovalent":[103],"chemotypes,":[104],"including":[105],"pyrazolo[1,5-a]pyrimidine":[107],"scaffold":[108],"exemplified":[109],"SGC-CK2-1,":[111],"as":[112,114],"well":[113],"emerging":[115],"scaffolds":[116],"bivalent":[118],"derivatives.":[120],"Among":[121],"inhibitors":[123],"discussed,":[124],"APL-5125":[125],"notably":[127],"progressed":[128],"an":[130],"probe":[134],"based":[135],"single-digit":[138],"nanomolar":[139],"potency,":[140],"excellent":[141],"favorable":[145],"properties":[148],"that":[149],"have":[150],"supported":[151],"advancement":[153],"into":[154],"Phase":[155],"1/2":[156],"clinical":[157],"trials.":[158],"conclude":[160],"outlining":[162],"future":[163],"directions":[164],"probe-enabled":[166],"interrogation":[167]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7236644875","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2026-11-20T00:00:00"}
